Webinar
Strawberry Creek Venture Masterclass Live
Join Matt Caspari, Managing Partner of Strawberry Creek Ventures, as he pulls back the curtain on how the team evaluates promising startups — and what separates compelling venture opportunities from the rest.
Matt will walk through the framework Strawberry Creek Ventures uses to evaluate potential investments, including deal dynamics, lead investor quality, execution, and team dynamics. He’ll explain how the team applies this scorecard to its diligence and investment decisions.
Whether you’re an experienced investor or exploring venture capital for the first time, this masterclass will provide a clearer view of the judgment behind a venture deal. Register to learn directly from Matt and bring your questions to the live discussion.
Want to access our Strawberry Creek Ventures startup deals to see, evaluate, and optionally invest? No cost, no commitment.
Why Attend?
- HomeUnderstand the criteria Strawberry Creek Ventures uses to evaluate startups
- HomeLearn how the team applies its scorecard throughout the diligence process
- HomeGain a practical framework for assessing venture opportunities and risk
Rated a Top 20 VC Firm by both TIME and CB Insights.
Alumni Ventures is America’s largest venture capital firm for individual investors.
About your presenter
Overview
Matt Caspari invests in mission-driven founders building the next generation of iconic companies—entrepreneurs tackling the world’s hardest, highest-stakes problems. He backs breakthrough technologies with the potential to redefine critical industries, unlock new markets, and create a more sustainable, secure future.
Before Alumni Ventures, Matt was a two-time venture-backed founder/CEO and a leader of the innovation team at Nike. He founded Aurora Biofuels, a deep-tech venture that grew to 100+ employees and secured more than $100 million in funding before its acquisition by Reliance Industries. Earlier, he advised life science multinationals at Cambridge Pharma Consultancy (acquired by IMS Health) and gained experience on Bloomberg’s M&A team. Matt holds a BS in Biochemistry from Georgetown University and an MBA with a Certificate in Entrepreneurship from UC Berkeley.
Funds actively worked on
Investment Area of Focus
His investment lens favors bold solutions to global challenges and durable advantages rooted in technology and aligned with long-term megatrends. This translates to surgical robots powered by physical AI, next-generation energy systems, space-based infrastructure, longevity therapeutics, and more. The through-line is the potential for extraordinary value creation at the intersection of deep science and global need.
Representative investments Matt has led for Alumni Ventures include Andromeda Surgical and Cytronic (Physical AI); Arda Therapeutics and Cambrian Biopharma (Technologies for the Human Body); Max Space and Orbital Operations (Space Infrastructure); and Fortera and Mainspring Energy (The New Energy Stack). Alumni Ventures’ Deep Tech portfolio also includes companies such as Axiom Space, Ayar Labs, Cohere, Frore Systems, Groq, Hawkeye360, Hayden AI, Lambda, Radiant, and Rigetti (Nasdaq: RGTI).